Phosphorylated sarm1, antibody, sarm1 phosphorylation inhibitor, prophylactic or therapeutic agent for neurodegenerative diseases, screening method, modified sarm1, and use
WO2017104796A1
Artificial rna restriction enzyme
WO2017094838A1
Fluorescent ligand for retinoid x receptor, and application thereof
WO2017061354A1
Gene expression cassette and product thereof
WO2017057308A1
Antibody for specifically recognizing and binding active-structure reic/dkk-3 protein, and monitoring for cancer treatment in which said anti-reic/dkk-3 antibody is used
WO2017002874A1
Drug for preventing or treating inflammatory bowel disease
WO2016178427A1
Poly(p-phenylenebenzobisoxazole) crystal and method for producing same, and composite material and method for producing same
WO2016170938A1
Non-human animal model of cancer and method for constructing same, cancer stem cell and method for producing same
WO2016159009A1
Cancer detection kit and method for acquiring data for cancer diagnosis
WO2016136851A1
Method for manufacturing substrate for surface enhanced raman spectroscopy, and substrate manufactured by said method
WO2016129583A1
Lactate dehydrogenase inhibitor and antiepileptic drug containing same
WO2017125993A1
Plant disease control agent containing lignin extract as active ingredient
US2016146835A1
Therapeutic agent, method of treatment and method for predicting the severity of systemic inflammatory response syndrome (SIRS), diseases caused or accompanied by neutrophil activation
CA2958573A1
Agent for treating and/or preventing diseases associated with immune abnormalities by combining biguanide antidiabetic drug with immunosuppressive factor blocking agent or costimulatory receptor agonist
CN105683752A
Method using abnormally-activated-cell detection to test for malignant tumors and abnormally-activated-cell apheresis-therapy apparatus
US2015080551A1
Lysine oligomer derivative and cartilage tissue marker made thereof
